Freestone Capital Holdings, LLC Idexx Laboratories Inc Transaction History

Freestone Capital Holdings, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$327.37 - $553.44 $65,801 - $111,241	-201 Reduced 24.22%	629 $221,000
Q1 2022 May 12, 2022	BUY	$466.52 - $631.01 $61,114 - $82,662	131 Added 18.74%	830 $454,000
Q4 2021 Feb 14, 2022	BUY	$586.54 - $666.48 $14,663 - $16,662	25 Added 3.71%	699 $460,000
Q3 2021 Nov 15, 2021	BUY	$621.9 - $705.76 $93,285 - $105,864	150 Added 28.63%	674 $419,000
Q2 2021 Aug 16, 2021	BUY	$486.36 - $637.08 $12,645 - $16,564	26 Added 5.22%	524 $331,000
Q1 2021 May 17, 2021	BUY	$465.18 - $551.79 $54,426 - $64,559	117 Added 30.71%	498 $244,000
Q4 2020 Feb 16, 2021	BUY	$383.85 - $499.87 $34,162 - $44,488	89 Added 30.48%	381 $190 Million
Q3 2020 Nov 06, 2020	BUY	$334.54 - $406.31 $97,685 - $118,642	292 New	292 $114,000

1,212

72.5M

167K

343K

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $34.3B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Freestone Capital Holdings, LLC with notifications on news.